HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

With Woodcock’s Retirement, US FDA Loses A Renaissance Woman

Executive Summary

The FDA will go on without Janet Woodcock, but it will likely take multiple people to fill in the gaps given her breadth of institutional knowledge, interests and skill sets, former close colleagues told the Pink Sheet.

You may also be interested in...



Janet Woodcock Retires From US FDA: ‘I’m Trying To Tie Up All The Loose Ends’

On the eve of departure after more than 37 years of service to FDA, the agency’s principal deputy commissioner discusses her legacy, issues that others will take up, and preparing the agency for change in a Pink Sheet interview.

Janet Woodcock Retires From US FDA: ‘I’m Trying To Tie Up All The Loose Ends’

On the eve of departure after more than 37 years of service to FDA, the agency’s principal deputy commissioner discusses her legacy, issues that others will take up, and preparing the agency for change in a Pink Sheet interview.

US FDA Chief Scientist Bumpus Will Become Principal Deputy Commissioner

When Janet Woodcock retires early next year, Namandjé Bumpus will take over as No. 2 in command at the FDA. Since joining the agency in 2022 from Johns Hopkins, her profolio has included health disparities, cosmetics, and drug review disputes.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS149368

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel